BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 30151969)

  • 1. Hypothyroidism associated with therapy for multi-drug-resistant tuberculosis in Australia.
    Cheung YM; Van K; Lan L; Barmanray R; Qian SY; Shi WY; Wong JLA; Hamblin PS; Colman PG; Topliss DJ; Denholm JT; Grossmann M
    Intern Med J; 2019 Mar; 49(3):364-372. PubMed ID: 30151969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Two cases of multi-drug-resistant pulmonary tuberculosis with para-aminosalicylic acid (PAS)-induced hypothyroidism].
    Mizutani H; Horiba M; Shindoh J; Kimura T; Son M; Wakahara K
    Kekkaku; 2001 Oct; 76(10):667-72. PubMed ID: 11712388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High rate of hypothyroidism among patients treated for multidrug-resistant tuberculosis in Lesotho.
    Satti H; Mafukidze A; Jooste PL; McLaughlin MM; Farmer PE; Seung KJ
    Int J Tuberc Lung Dis; 2012 Apr; 16(4):468-72. PubMed ID: 22326109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is hypothyroidism rare in multidrug resistance tuberculosis patients on treatment? A systematic review and meta-analysis.
    Tola HH; Holakouie-Naieni K; Lejisa T; Mansournia MA; Yaseri M; Tesfaye E; Mola M
    PLoS One; 2019; 14(6):e0218487. PubMed ID: 31211809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes is Associated with Severe Adverse Events in Multidrug-Resistant Tuberculosis.
    Muñoz-Torrico M; Caminero-Luna J; Migliori GB; D'Ambrosio L; Carrillo-Alduenda JL; Villareal-Velarde H; Torres-Cruz A; Flores-Vergara H; Martínez-Mendoza D; García-Sancho C; Centis R; Salazar-Lezama MÁ; Pérez-Padilla R
    Arch Bronconeumol; 2017 May; 53(5):245-250. PubMed ID: 28089216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid function in multidrug-resistant tuberculosis patients with or without human immunodeficiency virus (HIV) infection before commencement of MDR-TB drug regimen.
    Ige OM; Akinlade KS; Rahamon SK; Edem VF; Arinola OG
    Afr Health Sci; 2016 Jun; 16(2):596-602. PubMed ID: 27605977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High rate of hypothyroidism in multidrug-resistant tuberculosis patients co-infected with HIV in Mumbai, India.
    Andries A; Isaakidis P; Das M; Khan S; Paryani R; Desai C; Dalal A; Mansoor H; Verma R; Fernandes D; Sotgiu G; Migliori GB; Saranchuk P
    PLoS One; 2013; 8(10):e78313. PubMed ID: 24194919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced hypothyroidism in tuberculosis.
    Quiroz-Aldave JE; Durand-Vásquez MDC; Gamarra-Osorio ER; Concepción-Urteaga LA; Pecho-Silva S; Rodríguez-Hidalgo LA; Concepción-Zavaleta MJ
    Expert Rev Endocrinol Metab; 2024 May; 19(3):199-206. PubMed ID: 38258451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothyroidism during second-line treatment of multidrug-resistant tuberculosis: a prospective study.
    Bares R; Khalid N; Daniel H; Dittmann H; Reimold M; Gallwitz B; Schmotzer C
    Int J Tuberc Lung Dis; 2016 Jul; 20(7):876-81. PubMed ID: 27287638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid profile status of patients treated for multidrug-resistant tuberculosis in state of Meghalaya, India.
    Saharia GK; Ruram AA; Lyngwa J
    Indian J Tuberc; 2015 Jul; 62(3):166-70. PubMed ID: 26600329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug-resistant tuberculosis in Western Australia, 1998-2012.
    Francis JR; Blyth CC; Colby S; Fagan JM; Waring J
    Med J Aust; 2014 Apr; 200(6):328-32. PubMed ID: 24702090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial.
    Lee M; Mok J; Kim DK; Shim TS; Koh WJ; Jeon D; Lee T; Lee SH; Kim JS; Park JS; Lee JY; Kim SY; Lee JH; Jo KW; Jhun BW; Kang YA; Ahn JH; Kim CK; Shin S; Song T; Shin SJ; Kim YR; Ahn H; Hahn S; Won HJ; Jang JY; Cho SN; Yim JJ
    Trials; 2019 Jan; 20(1):57. PubMed ID: 30651149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug-resistant tuberculosis of the spine--is it the beginning of the end? A study of twenty-five culture proven multidrug-resistant tuberculosis spine patients.
    Pawar UM; Kundnani V; Agashe V; Nene A; Nene A
    Spine (Phila Pa 1976); 2009 Oct; 34(22):E806-10. PubMed ID: 19829244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study.
    Gobena D; Ameya G; Haile K; Abreha G; Worku Y; Debela T
    Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):30. PubMed ID: 29970076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients.
    Atif M; Bashir A; Ahmad N; Fatima RK; Saba S; Scahill S
    BMC Infect Dis; 2017 Sep; 17(1):655. PubMed ID: 28962599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse effects of multidrug-resistant tuberculosis treatment with a standardized regimen: a report from Iran.
    Baghaei P; Tabarsi P; Dorriz D; Marjani M; Shamaei M; Pooramiri MV; Mansouri D; Farnia P; Masjedi M; Velayati A
    Am J Ther; 2011; 18(2):e29-34. PubMed ID: 20019591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for treatment success in patients with multidrug-resistant tuberculosis in China.
    Fan YM; Ding SP; Bao ZJ; Wu LM; Zhen LB; Xia Q; Zhu M
    Int J Tuberc Lung Dis; 2018 Mar; 22(3):300-305. PubMed ID: 29471908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis associated with prothionamide for treatment of multidrug-resistant tuberculosis.
    Hsu HL; Bai KJ; Chiang YC; Lin SJ; Yu MC
    J Formos Med Assoc; 2010 Dec; 109(12):923-7. PubMed ID: 21195892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis.
    Centers for Disease Control and Prevention
    MMWR Recomm Rep; 2013 Oct; 62(RR-09):1-12. PubMed ID: 24157696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality among MDR-TB cases: comparison with drug-susceptible tuberculosis and associated factors.
    Chung-Delgado K; Guillen-Bravo S; Revilla-Montag A; Bernabe-Ortiz A
    PLoS One; 2015; 10(3):e0119332. PubMed ID: 25790076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.